Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsten Axelsen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Health Affairs Scholar|October 23, 2025
Models attempting to quantify the relationship between drug development and financial return are missing a key element: the effect on post-approval researchDan Crippen, Kirsten Axelsen
Health Affairs Scholar|December 12, 2024
Evidence to inform biopharmaceutical policy: call for research on the impact of public policies on investment in drug developmentSandra Barbosu, Kirsten Axelsen, Stephen Ezell
The American Journal of Managed Care|February 11, 2005
Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medicationsJerome Wilson, Kirsten Axelsen, Simon Tang
Health Affairs Scholar|November 28, 2025
Savings from biosimilars and Medicare formulary accessKirsten Axelsen, Delphine Courmier, Ge Bai, et al.
Menopause (New York, N.Y.)|January 25, 2003
A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new usersJames A Simon, Susan Wysocki, Jane Brandman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 18, 2015
Optimizing the leveraging of real-world data to improve the development and use of medicinesMarc L Berger, Craig Lipset, Alex Gutteridge, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
The American Journal of Managed Care|December 19, 2006
Impact of statin copayments on adherence and medical care utilization and expendituresTeresa B Gibson, Tami L Mark, Kirsten Axelsen, et al.
Current Medical Research and Opinion|April 7, 2009
Generic and therapeutic statin switches and disruptions in therapyRichard H Chapman, Joshua S Benner, Prafulla Girase, et al.
Medical Care|September 28, 2016
Real-World Data: Responses to Zito and DoshiAnirban Basu, Kirsten Axelsen, David C Grabowski, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Health Affairs Scholar|October 23, 2025
Models attempting to quantify the relationship between drug development and financial return are missing a key element: the effect on post-approval researchDan Crippen, Kirsten Axelsen
Health Affairs Scholar|December 12, 2024
Evidence to inform biopharmaceutical policy: call for research on the impact of public policies on investment in drug developmentSandra Barbosu, Kirsten Axelsen, Stephen Ezell
The American Journal of Managed Care|February 11, 2005
Medicaid prescription drug access restrictions: exploring the effect on patient persistence with hypertension medicationsJerome Wilson, Kirsten Axelsen, Simon Tang
Health Affairs Scholar|November 28, 2025
Savings from biosimilars and Medicare formulary accessKirsten Axelsen, Delphine Courmier, Ge Bai, et al.
Menopause (New York, N.Y.)|January 25, 2003
A comparison of therapy continuation rates of different hormone replacement agents: a 9-month retrospective, longitudinal analysis of pharmacy claims among new usersJames A Simon, Susan Wysocki, Jane Brandman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 18, 2015
Optimizing the leveraging of real-world data to improve the development and use of medicinesMarc L Berger, Craig Lipset, Alex Gutteridge, et al.
The American Journal of Managed Care|September 12, 2006
The effects of prescription drug copayments on statin adherenceTeresa B Gibson, Tami L Mark, Kimberly A McGuigan, et al.
The American Journal of Managed Care|December 19, 2006
Impact of statin copayments on adherence and medical care utilization and expendituresTeresa B Gibson, Tami L Mark, Kirsten Axelsen, et al.
Current Medical Research and Opinion|April 7, 2009
Generic and therapeutic statin switches and disruptions in therapyRichard H Chapman, Joshua S Benner, Prafulla Girase, et al.
Medical Care|September 28, 2016
Real-World Data: Responses to Zito and DoshiAnirban Basu, Kirsten Axelsen, David C Grabowski, et al.
Pageof 2